Cited by 418Pharmacogenetics and Drug MetabolismDiabetes Treatment and ManagementMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Accumulation of metformin by tissues of the normal and diabetic mouse

Wilcock, C., Bailey, C. J.·1994·Xenobiotica

Open this paper in CoChat — free account

Abstract

1. Tissue accumulation of the antihyperglycaemic agent metformin (dimethylbiguanide) was examined after oral administration to the normal and streptozotocin (STZ) diabetic mouse. 2. Metformin (50 mg/kg body weight containing 14C-metformin 25 microCi/kg body weight), which is stable and not metabolized, resulted in maximum plasma concentrations at 0.5 h which declined to < 5% of maximum by 24 h. Maximum plasma concentrations (mumol/l, mean +/- SE) in the hepatic portal vein (normal 51.7 +/- 5.4, STZ 61.5 +/- 8.0) were higher than in the inferior vena cava (normal 29.0 +/- 2.8, STZ 35.4 +/- 5.9). 3. The greatest accumulation of metformin occurred in tissues of the small intestine, where maximum concentrations were > 1000 mumol/kg wet weight at 0.5-2 h, but declined to < 2% of maximum by 24 h. 4. Stomach, colon, salivary gland, kidney and liver accumulated metformin more than two-fold, and concentrations of the drug in heart and skeletal (gastrocnemius) muscle were greater than plasma concentrations on some occasions up to 8 h. 5. In a separate study, i.v.-administered metformin was selectively accumulated by tissues of the small intestine. Thus, retention of metformin by tissues of the small intestine may represent a deep compartment for the drug.

Integrity signals

Registry

Crossref · 10.3109/00498259409043220

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Verapamil
Singh, B. N., Ellrodt, G. A., & Peter, C. T. (1978) · Drugs · doi:10.2165/00003495-197815030-00001 · Cited by 835
Biguanides and NIDDM
Bailey, C. J. (1992) · Diabetes Care · doi:10.2337/diacare.15.6.755 · Cited by 593
Self-citation
Metformin kinetics in healthy subjects and in patients with diabetes mellitus.
Tucker, G., Casey, C., Phillips, P., Connor, H., Ward, J. D., & Woods, H. (1981) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1981.tb01206.x · Cited by 503
Pharmacokinetics of Metformin After Intravenous and Oral Administration to Man
Pentik�inen, P. J., Neuvonen, P. J., & Penttil�, A. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562061 · Cited by 348
Disposition of metformin (N,N‐dimethylbiguanide) in man
Sirtori, C. R., Franceschini, G., Galli-Kienle, M., Cighetti, G., Galli, G., Bondioli, A., & Conti, F. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978246683 · Cited by 222
Metformin: a review of its pharmacological properties and therapeutic use.
Ls, H. (1979) · PubMed · Cited by 175
Determination of glucose by an automatic analyser
Stevens, J. F. (1971) · Clinica Chimica Acta · doi:10.1016/0009-8981(71)90332-9 · Cited by 166
Gastrointestinal Motility.
Konturek, S. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-5-789_4 · Cited by 158
Effect of metformin on glucose metabolism in the splanchnic bed
Bailey, C. J., Wilcock, C., & Day, C. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09093.x · Cited by 131
Self-citation
Metformin in the digestive tract
Vidon, N., Chaussade, S., Noël, M., Franchisseur, C., Huchet, B., & Bernier, J. J. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80022-6 · Cited by 117

Show all 23 references

Research works printed but not linked: 7

Bailey C. J., 1988, Balliere's Clinical Endocrinology and Metabolism, 2, 455
Bailey C. J., 1986, Diabete et Metabolisme, 12, 212
Cigolini M., 1984, Diabete et Metabolisme, 10, 311
Cohen P. Y., 1961, Therapie, 16, 109
Hermann L. S, 1979, Diabete et Metabolisme, 5, 233
Mordes J. P., 1985, Joslin's Diabetes Mellitus12th edn, 110
Noel M, 1979, Research and Clinical Forums, 1, 35

Sorted by citations

Items 201–300 of 414

Transfer of metformin across monolayers of human intestinal Caco-2 cells and across rat intestine
Nicklin, P. L., Keates, A. C., Page, T., & Bailey, C. J. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04259-8 · Cited by 38
Self-citation
High Accumulation of Metformin in Colonic Tissue of Subjects With Diabetes or the Metabolic Syndrome
Paleari, L., Burhenne, J., Weiß, J., Foersch, S., Roth, W., Parodi, A. F., Gnant, M., Bachleitner‐Hofmann, T., Scherer, D., Ulrich, C. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.12.040 · Cited by 36
Preclinical Pharmacology of Biguanides
Wiernsperger, N. F. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-09127-2_12 · Cited by 36
Metformin inhibits 7,12-dimethylbenz[a]anthracene-induced breast carcinogenesis and adduct formation in human breast cells by inhibiting the cytochrome P4501A1/aryl hydrocarbon receptor signaling pathway
Maayah, Z. H., Ghebeh, H., Alhaider, A. A., El‐Kadi, A. O. S., Soshilov, A. A., Denison, M. S., Ansari, M. A., & Korashy, H. M. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.02.007 · Cited by 35
Metformin induces tolerogenicity of dendritic cells by promoting metabolic reprogramming
Liu, X., Yu, P., Xu, Y., Wang, Y., Chen, J., Tang, F., Hu, Z., Zhou, J., Liu, L., Qiu, W., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04932-3 · Cited by 33
Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation
Moonira, T., Chachra, S. S., Ford, B. E., Marín, S., Alshawi, A., Adam-Primus, N. S., Arden, C., Al‐Oanzi, Z. H., Foretz, M., Viollet, B., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012533 · Cited by 35
Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro
UEHARA, T., Mitsuhashi, A., Tsuruoka, N., & Shozu, M. (2014) · Oncology Reports · doi:10.3892/or.2014.3611 · Cited by 36
The antidiabetic drug metformin decreases mitochondrial respiration and tricarboxylic acid cycle activity in cultured primary rat astrocytes
Hohnholt, M. C., Blumrich, E., Waagepetersen, H. S., & Dringen, R. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24050 · Cited by 34
Development and Evaluation of an 18F-Radiolabeled Monocyclam Derivative for Imaging CXCR4 Expression
Bričkutė, D., Braga, M. C., Kaliszczak, M. A., Barnes, C., Lau, D., Carroll, L. S., Stevens, E., Trousil, S., Alam, I. S., Nguyen, Q., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00069 · Cited by 34
MATE2 Expression Is Associated With Cancer Cell Response to Metformin
Chowdhury, S., Yung, E., Pintilie, M., Muaddi, H., Chaib, S., Yeung, M., Fusciello, M., Sykes, J., Pitcher, B., Hagenkort, A., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165214 · Cited by 33
Metformin: From diabetes to cancer to prolongation of life
Sirtori, C. R., Castiglione, S., & Pavanello, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107367 · Cited by 38
Update on the Protective Molecular Pathways Improving Pancreatic Beta-Cell Dysfunction
Puddu, A., Sanguineti, R., Mach, F., Dallegri, F., Viviani, G. L., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/750540 · Cited by 33
The alleviative effects of metformin for lipopolysaccharide-induced acute lung injury rat model and its underlying mechanism
Zhang, X., Shang, F., Hui, L., Zang, K., & Sun, G. (2017) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2017.05.001 · Cited by 33
Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug
Saengboonmee, C., Sanlung, T., & Wongkham, S. (2021) · Anticancer Research · doi:10.21873/anticanres.15410 · Cited by 36
Inhibitory effect of metformin on formation of advanced glycation end products
Tanaka, Y., Iwamoto, H., Onuma, T., & Kawamori, R. (1997) · Current Therapeutic Research · doi:10.1016/s0011-393x(97)80103-8 · Cited by 33
Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes
Henry, R. R., Frías, J. P., Walsh, B., Skare, S., Hemming, J., Burns, C. M., Bicsak, T. A., Baron, A., & Fineman, M. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203946 · Cited by 33
Impact of Metformin on Male Reproduction
Ferreira, C., Sousa, M., Rabaça, A., Oliveira, P. F., Alves, M. G., & Sá, R. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710150041 · Cited by 33
Bioadhesive Delivery of Metformin Using Prosopis Gum with Antidiabetic Potential
Adikwu, M. U., Yoshikawa, Y., & Takada, K. (2003) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.26.662 · Cited by 32
Metformin inhibits visceral allodynia and increased gut permeability induced by stress in rats
Nozu, T., Miyagishi, S., Kumei, S., Nozu, R., Takakusaki, K., & Okumura, T. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14367 · Cited by 32
Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock
Matsiukevich, D., Piraino, G., Lahni, P. M., Hake, P. W., Wolfe, V., O’Connor, M. P., James, J., & Zingarelli, B. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.05.027 · Cited by 31
Why Does the Intestine Lack Basolateral Efflux Transporters for Cationic Compounds? A Provocative Hypothesis
Proctor, W. R., Ming, X., Bourdet, D. L., Han, T. K., Everett, R., & Thakker, D. R. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.040 · Cited by 31
Metformin
Stümvoll, M., Häring, H., & Matthaei, S. (2007) · Endocrine Research · doi:10.1080/07435800701743828 · Cited by 31
Lipopolysaccharide-Induced Loss of Cultured Rat Myenteric Neurons - Role of AMP-Activated Protein Kinase
Voss, U., & Ekblad, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114044 · Cited by 32
Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET/CT interpretation of the bowel
Lee, S. H., Jin, S., Lee, H. S., Ryu, J., & Lee, J. J. (2016) · Annals of Nuclear Medicine · doi:10.1007/s12149-016-1106-7 · Cited by 30
Inhalational supplementation of metformin butyrate: A strategy for prevention and cure of various pulmonary disorders
Maniar, K., Singh, V., Moideen, A., Bhattacharyya, R., Chakrabarti, A., & Banerjee, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.021 · Cited by 30
Effect of metformin on survival rate in experimental sepsis
Gras, V., Bouffandeau, B., Montravers, P., & Lalau, J. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70261-6 · Cited by 29
Therapeutics for Equine Endocrine Disorders
Durham, A. E. (2017) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2016.11.003 · Cited by 30
Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells
Garrido, M. P., Vera, C., Vega, M., Quest, A. F. G., & Romero, C. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918770984 · Cited by 29
In VitroandIn VivoEffects of Metformin on Osteopontin Expression in Mice Adipose-Derived Multipotent Stromal Cells and Adipose Tissue
Śmieszek, A., Basińska, K., Chrząstek, K., & Marycz, K. (2015) · Journal of Diabetes Research · doi:10.1155/2015/814896 · Cited by 29
Metformin exaggerates phenylephrine-induced AMPK phosphorylation independent of CaMKKβ and attenuates contractile response in endothelium-denuded rat aorta
Pyla, R., Osman, I., Pichavaram, P., Hansen, P., & Segar, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.024 · Cited by 30
Opposite effects of a glucokinase activator and metformin on glucose‐regulated gene expression in hepatocytes
Al‐Oanzi, Z. H., Fountana, S., Moonira, T., Tudhope, S. J., Petrie, J. L., Alshawi, A., Patman, G., Arden, C., Reeves, H. L., & Agius, L. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12910 · Cited by 29
Design, optimization, characterization, and in vivo evaluation of sterosomes as a carrier of metformin for treatment of lung cancer
Osama, H., Sayed, O. M., Hussein, R. R. S., Abdelrahim, M. E. A., & Elberry, A. A. (2019) · Journal of Liposome Research · doi:10.1080/08982104.2019.1610434 · Cited by 29
Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes
Anwardeen, N. R., Naja, K., & Elrayess, M. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1506767 · Cited by 29
Metformin treatment for 8 days impacts multiple intestinal parameters in high-fat high-sucrose fed mice
Bravard, A., Gérard, C., Defois, C., Benoit, B., Makki, K., Meugnier, E., Rainteau, D. P., Rieusset, J., Godet, M., & Vidal, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-95117-0 · Cited by 28
Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis
Peng, A., Gong, C., Xu, Y., Liang, X., Chen, X., Hong, W., & Yan, J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1183879 · Cited by 27
The Hormetic Effect of Metformin: “Less Is More”?
Panfoli, I., Puddu, A., Bertola, N., Ravera, S., & Maggi, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126297 · Cited by 29
Metformin and intestinal glucose handling
Bailey, C. J. (1995) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610110505 · Cited by 27
Self-citation
Metformin does not compromise energy status in human skeletal muscle at rest or during acute exercise: A randomised, crossover trial
Kristensen, J. M., Lillelund, C., Kjøbsted, R., Birk, J. B., Andersen, N. R., Nybo, L., Mellberg, K., Balendran, A., Richter, E. A., & Wojtaszewski, J. F. P. (2019) · Physiological Reports · doi:10.14814/phy2.14307 · Cited by 30
AMP-activated protein kinase and its multifaceted regulation of hepatic metabolism
Fullerton, M. D. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000273 · Cited by 28
Metformin Suppresses Development of the Echinococcus multilocularis Larval Stage by Targeting the TOR Pathway
Loos, J. A., Dávila, V. A., Brehm, K., & Cumino, A. C. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01808-19 · Cited by 26
Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area
Tulipano, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313068 · Cited by 26
Helicobacter pylori Infection Decreases Metformin Tolerance in Patients with Type 2 Diabetes Mellitus
Huang, Y., Sun, J., Wang, X., Tao, X., Wang, H., & Tan, W. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0203 · Cited by 24
Effects of metformin on retinoblastoma growth in vitro and in vivo
Brodowska, K., Theodoropoulou, S., zu Hörste, M. M., Paschalis, E. I., Takeuchi, K., SCOTT, G., Ramsey, D. J., Kiernan, E. A., Hoang, M. V., Cichy, J., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2650 · Cited by 24
Effects of metformin on bile salt transport by monolayers of human intestinal Caco‐2 cells
Carter, D., Howlett, H. C. S., Wiernsperger, N. F., & Bailey, C. J. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00223.x · Cited by 25
Self-citation
Potential biomarker of metformin action
He, L., Meng, S., Germain‐Lee, E. L., Radovick, S., & Wondisford, F. E. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0084 · Cited by 23
A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer
Sambi, M., Samuel, V., Qorri, B., Haq, S., Burov, S. V., Арнольдовна, М. Е., Harless, W. W., & Szewczuk, M. R. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s242514 · Cited by 23
Severe metformin intoxication treated with prolonged haemodialyses and plasma exchange
Türkçüer, İ., Erdur, B., Sarı, İ., Yüksel, A., Tura, P., & Yuksel, S. (2008) · European Journal of Emergency Medicine · doi:10.1097/mej.0b013e32830a7567 · Cited by 23
Metformin May Be Associated with False-Negative Cancer Detection in the Gastrointestinal Tract on Pet/Ct
Steenkamp, D., McDonnell, M. E., & Meibom, S. K. (2014) · Endocrine Practice · doi:10.4158/ep14127.ra · Cited by 23
Let-7 underlies metformin-induced inhibition of hepatic glucose production
Xie, D., Chen, F., Zhang, Y., Shi, B., Song, J., Chaudhari, K., Yang, S., Zhang, G. J., Sun, X., Taylor, H. S., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122217119 · Cited by 24
Metformin prevents the onset and progression of intervertebral disc degeneration: New insights and potential mechanisms (Review)
Yang, W., Yang, Y., Wang, Y., Gao, Z., Zhang, J., Gao, W., Chen, Y., Lü, Y., Wang, H., Zhou, L., et al. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5395 · Cited by 22
Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control
Sebo, Z. L., Chakrabarty, R. P., Grant, R. A., D’Alessandro, K. B., Koss, A., Blum, J. L. E., Davidson, S. M., Reczek, C. R., & Chandel, N. S. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01530-y · Cited by 21
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
Amano, T., Murakami, A., Murakami, T., & Chano, T. (2021) · Antioxidants · doi:10.3390/antiox10020187 · Cited by 21
Increased Expression of Hepatic Organic Cation Transporter 1 and Hepatic Distribution of Metformin in High-fat Diet-induced Obese Mice
Jang, E.-H., Klm, H.-K., Park, C., & Kang, J. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-nt-010 · Cited by 21
Medium Renewal Blocks Anti-Proliferative Effects of Metformin in Cultured MDA-MB-231 Breast Cancer Cells
Rajh, M., Dolinar, K., Miš, K., Pavlin, M., & Pirkmajer, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154747 · Cited by 22
Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes
Huang, Y., Sun, J., Wang, X., Tao, X., Wang, H., & Tan, W. (2015) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12290 · Cited by 20
Metformin Prevents an Adaptive Increase in GSH and Induces Apoptosis Under the Conditions of GSH Deficiency in H4IIE Cells∗
Bae, E. J., Cho, M. J., & Kim, S. G. (2007) · Journal of Toxicology and Environmental Health · doi:10.1080/15287390701434430 · Cited by 20
The desert gerbil Psammomys obesus as a model for metformin-sensitive nutritional type 2 diabetes to protect hepatocellular metabolic damage: Impact of mitochondrial redox state
Gouaref, I., Détaille, D., Wiernsperger, N. F., Khan, N. A., Leverve, X. M., & Koceir, E.-A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172053 · Cited by 21
Patient-derived microphysiological model identifies the therapeutic potential of metformin for thoracic aortic aneurysm
Ma, W., Zhang, J., Liu, S., Yan, S., Xu, K., Zhang, Y. S., Abudupataer, M., Yang, M., Zhu, S., Xiang, B., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104080 · Cited by 19
Could Metformin and Resveratrol Support Glioblastoma Treatment? A Mechanistic View at the Cellular Level
Ibrahim, R. S., Ibrahim, S. S., El-Naas, A., Koklesová, L., Kubatka, P., & Büsselberg, D. (2023) · Cancers · doi:10.3390/cancers15133368 · Cited by 19
The gastrointestinal tract is a major source of the acute metformin-stimulated rise in GDF15
Kincaid, J. W. R., Rimmington, D., Tadross, J. A., Cimino, I., Zvetkova, I., Kaser, A., Richards, P., Patel, S., O’Rahilly, S., & Coll, A. P. (2024) · Scientific Reports · doi:10.1038/s41598-024-51866-2 · Cited by 20
Acute Effect of Metformin on Postprandial Hypertriglyceridemia through Delayed Gastric Emptying
Sato, D., Morino, K., Nakagawa, F., Murata, K., Sekine, O., Beppu, F., Gotoh, N., Ugi, S., & Maegawa, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061282 · Cited by 22
Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration – A Mass Spectrometry Imaging Study of the Perfused Rat Liver
Calza, G., Nyberg, E., Mäkinen, M., Soliymani, R., Cascone, A., Lindholm, D., Barborini, E., Baumann, M., Lalowski, M. M., & Eriksson, O. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00141 · Cited by 19
The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects
Khatami, F., Mohajeri‐Tehrani, M. R., & Tavangar, S. M. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190228102212 · Cited by 19
Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-β1/Smad3 Signaling
Wang, Y., Wang, Z., Yang, H., Chen, S., Zheng, D., Liu, X., Jiang, Q., & Chen, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.887497 · Cited by 19
Molecular action and pharmacogenetics of metformin: current understanding of an old drug
Rena, G., Pearson, E. R., & Sakamoto, K. (2012) · Diabetes Management · doi:10.2217/dmt.12.42 · Cited by 19
Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells
Garrido, M. P., Salvatierra, R., Valenzuela, M., Vallejos, C., Bruneau, N., Hernández, A., Vega, M., Selman, A., Quest, A. F. G., & Romero, C. (2020) · Pharmaceuticals · doi:10.3390/ph13100315 · Cited by 18
Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of Metformin
Dahan, A., Porat, D., Marković, M., Zur, M., Kister, O., & Langguth, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111873 · Cited by 18
Metformin's Intrinsic Blood-to-Plasma Partition Ratio (B/P): Reconciling the Perceived High In Vivo B/P > 10 with the In Vitro Equilibrium Value of Unity
Xie, F., Ke, A. B., Bowers, G. D., & Zamek‐Gliszczynski, M. J. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225698 · Cited by 19
Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2
Biernacka, K. M., Persad, R. A., Bahl, A. K., Gillatt, D. A., Holly, J. M. P., & Perks, C. M. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0095 · Cited by 18
Metformin inhibition of colorectal cancer cell migration is associated with rebuilt adherens junctions and FAK downregulation
Amable, G., Martínez-León, E., Picco, M. E., Nemirovsky, S. I., Rozengurt, E., & Rey, O. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29677 · Cited by 17
Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation
Cai, S., Deng, Y., Zou, Z., Tian, W., Tang, Z., Li, J., Tan, Z., Wu, Z., Han, Z., Wen, B., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217694 · Cited by 18
Treatment with AICAR inhibits blastocyst development, trophectoderm differentiation and tight junction formation and function in mice
Calder, M. D., Edwards, N. A., Betts, D. H., & Watson, A. J. (2017) · Molecular Human Reproduction · doi:10.1093/molehr/gax050 · Cited by 16
Metformin action in the gut―insight provided by [18F]FDG PET imaging
Tsuchida, H., Morita, Y., Nogami, M., & Ogawa, W. (2021) · Diabetology International · doi:10.1007/s13340-021-00545-y · Cited by 16
Metformin—mechanisms of its glycemia-reducing effect
Drewe, J., Foretz, M., & Krähenbühl, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100106 · Cited by 18
Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
Papini, N., Giussani, P., & Tringali, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168884 · Cited by 16
In vitro exposure to metformin activates human spermatozoa at therapeutically relevant concentrations
Yang, Y., Chen, H., Weng, S., Pan, T., Chen, W., Wang, F., Luo, T., & Tang, Y. (2020) · Andrology · doi:10.1111/andr.12755 · Cited by 15
Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin
Borg, M. J., Rayner, C. K., Jones, K. L., Horowitz, M., Xie, C., & Wu, T. (2020) · Pharmaceuticals · doi:10.3390/ph13110410 · Cited by 15
Protective effect of metformin against gentamicin induced nephrotoxicity in rabbits.
Janjua, A., Waheed, A., & Bakhtiar, S. (2014) · PubMed · Cited by 15
Visualizing the effects of metformin on tumor growth, vascularity, and metabolism in head and neck cancer
Verma, A., Rich, L. J., Vincent–Chong, V. K., & Seshadri, M. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12705 · Cited by 15
Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects
Abebe, B. T., Weiß, M., Modeß, C., Tadken, T., Wegner, D., Meyer, M. J., Schwantes, U., Neumeister, C., Scheuch, E., Schulz, H., et al. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1523 · Cited by 15
The potent, indirect adenosine monophosphate-activated protein kinase activator R419 attenuates mitogen-activated protein kinase signaling, inhibits nociceptor excitability, and reduces pain hypersensitivity in mice
Mejia, G. L., Asiedu, M. N., Hitoshi, Y., Dussor, G. O., & Price, T. J. (2016) · PAIN Reports · doi:10.1097/pr9.0000000000000562 · Cited by 14
The role of MicroRNA networks in tissue-specific direct and indirect effects of metformin and its application
Yang, Q., Wang, G., Fang, D., Gao, X., Yu, L., Wang, L., Wu, J., Zeng, M., & Luo, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113130 · Cited by 14
Metformin-NSAIDs Molecular Salts: A Path towards Enhanced Oral Bioavailability and Stability
Acebedo-Martínez, F. J., Domínguez‐Martín, A., Alarcón-Payer, C., Garcés-Bastida, C., Verdugo‐Escamilla, C., Gómez‐Morales, J., & Choquesillo‐Lazarte, D. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020449 · Cited by 15
Metformin Increases Cortisol Regeneration by 11βHSD1 in Obese Men With and Without Type 2 Diabetes Mellitus
Anderson, A. J., Andrew, R., Homer, N. Z. M., Jones, G. C., Smith, K., Livingstone, D. E. W., Walker, B. R., & Stimson, R. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2069 · Cited by 14
Literature review of the clinical characteristics of metformin-induced hepatotoxicity
Wang, C., Deng, H., Xu, Y., & Liu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.969505 · Cited by 13
Metformin-regulated glucose flux from the circulation to the intestinal lumen
Sakaguchi, K., Sugawara, K., Hosokawa, Y., Ito, J., Morita, Y., Mizuma, H., Watanabe, Y., Kimura, Y., Aburaya, S., Takahashi, M., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00755-4 · Cited by 16
Pharmacological Mimicking of Caloric Restriction Elicits Epigenetic Reprogramming of Differentiated Cells to Stem-Like Self-Renewal States
Oliveras‐Ferraros, C., Vázquez‐Martín, A., & Menéndez, J. A. (2010) · Rejuvenation Research · doi:10.1089/rej.2010.1022 · Cited by 14
Development of a capillary electrophoresis–mass spectrometry method for the analysis of metformin and its transformation product guanylurea in biota
Knoll, S., Jacob, S., Mieck, S., Triebskorn, R., Braunbeck, T. A., & Hühn, C. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02759-6 · Cited by 13
Evaluation of systemic and brain pharmacokinetic parameters for repurposing metformin using intravenous bolus administration
Sharma, S., Zhang, Y., Patel, D., Akter, K. A., Bagchi, S., Sifat, A. E., Nozohouri, E., Ahn, Y., Karamyan, V. T., Bickel, U., et al. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002152 · Cited by 13
Metformin as a cellular protector; a synoptic view of modern evidences.
Wiernsperger, N. F. (2015) · Europe PMC (PubMed Central) · Cited by 13
Metformin and risk of gingival/periodontal diseases in diabetes patients: A retrospective cohort study
Tseng, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1036885 · Cited by 12
Metformin Ameliorates D-Galactose-Induced Senescent Human Bone Marrow-Derived Mesenchymal Stem Cells by Enhancing Autophagy
Ye, P., Feng, L., Zhang, D., Li, R., Wen, Y., Tong, X., Shi, S., & Dong, C. (2023) · Stem Cells International · doi:10.1155/2023/1429642 · Cited by 13
Metformin increases the uptake of glucose into the gut from the circulation in high-fat diet-fed male mice, which is enhanced by a reduction in whole-body Slc2a2 expression
Morrice, N., Vainio, S., Mikkola, K., van Aalten, L., Gallagher, J. R., Ashford, M. L. J., McNeilly, A. D., McCrimmon, R. J., Grosfeld, A., Serradas, P., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101807 · Cited by 12
Differential increments of basal glucagon‐like‐1 peptide concentration among SLC 47A1 rs2289669 genotypes were associated with inter‐individual variability in glycaemic response to metformin in Chinese people with newly diagnosed Type 2 diabetes
Liang, H., Xu, W., Zhou, L., Yang, W., & Weng, J. (2017) · Diabetic Medicine · doi:10.1111/dme.13351 · Cited by 12
Potentiating effect of metformin on insulin-induced glucose uptake and glycogen metabolism within Xenopus oocytes
Détaille, D., Wiernsperger, N. F., & Devos, P. (1998) · Diabetologia · doi:10.1007/s001250050859 · Cited by 12
Metformin induction of heat shock factor 1 activation and the mitochondrial unfolded protein response alleviate cardiac remodeling in spontaneously hypertensive rats
Xu, M., Li, L., He, X., Lu, X., Bi, X., Li, Q., & Xue, X. (2024) · The FASEB Journal · doi:10.1096/fj.202400070r · Cited by 11
Metformin Modifies the Gut Microbiota of Mice Infected with Helicobacter pylori
Jauvain, M., Courtois, S., Lehours, P., & Bessède, E. (2021) · Pharmaceuticals · doi:10.3390/ph14040329 · Cited by 12
Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy
Samuel, S. M., Varghese, E., Satheesh, N. J., Triggle, C. R., & Büsselberg, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114911 · Cited by 14
Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive review
Petakh, P., Kamyshna, I. I., & Kamyshnyi, O. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1260633 · Cited by 11
A Mechanism of Action of Metformin in the Brain: Prevention of Methylglyoxal-Induced Glutamatergic Impairment in Acute Hippocampal Slices
Vizuete, A. F. K., Fróes, F. T., Seady, M., Hansen, F., Ligabue‐Braun, R., Gonçalves, C., & Souza, D. O. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03774-1 · Cited by 11

Authors: Wilcock, C., & Bailey, C. J.
Affiliations: Aston University (GB)
ORCID: Bailey, C. J.
Venue: Xenobiotica
Publisher: Informa UK Limited
Published: 1994-01
Volume: 24
Issue: 1
Pages: 49-57
ISSN: 0049-8254 (ISSN-L)
1366-5928
DOI: 10.3109/00498259409043220
OpenAlex: W2136667764
Cited by: 418
References: 23
Citations by year: 2026: 6 · 2025: 14 · 2024: 20 · 2023: 23 · 2022: 22 · 2021: 23 · 2020: 21 · 2019: 24 · 2018: 30 · 2017: 31 · 2016: 26 · 2015: 31 · 2014: 30 · 2013: 19 · 2012: 12
FWCI: 2.92
Type: journal article
Language: en
Open access: closed
Locations: Xenobiotica (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: metformin, tissue accumulation, streptozotocin-induced diabetes, small intestine, drug retention, plasma concentration, oral administration, antidiabetic drugs, drug distribution
MeSH terms: Administration, Oral, Animals, Diabetes Mellitus, Experimental, Digestive System, Injections, Intravenous, Male, Metformin, Mice, Inbred Strains, Tissue Distribution, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Accumulation of metformin by tissues of the normal and diabetic mouse

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks